Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹511.7 Cr 4% 29.9% 182.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,507.0 Cr 2.8% 7.4% 14.5% Stock Analytics
DIVIS LABORATORIES ₹190,744.0 Cr 6.4% 8.3% 0.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹168,250.0 Cr 2.1% 8.7% 47.7% Stock Analytics
CIPLA ₹116,213.0 Cr 0.5% 3.6% -5.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,980.0 Cr -7.6% -2.2% -5.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

4%

29.9%

182.3%

SENSEX

-1.4%

4.4%

-7.6%


You may also like the below Video Courses